| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kane Biotech Inc (OTCQB: KNBIF)
KNBIF Technical Analysis
5
| As on 2nd May 2025 KNBIF STOCK Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.07 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KNBIFSTOCK Price
| Open | 0.05 | Change | Price | % |
| High | 0.05 | 1 Day | 0.00 | 0.00 |
| Low | 0.05 | 1 Week | -0.02 | -28.57 |
| Close | 0.05 | 1 Month | -0.05 | -50.00 |
| Volume | 12000 | 1 Year | -0.02 | -28.57 |
| 52 Week High 0.11 | 52 Week Low 0.04 | ||||
OTCQB USA Most Active Stocks
| FNMA | 4.98 | 9.69% |
| BMIX | 0.01 | % |
| BTCWF | 0.10 | 150.00% |
| FMCC | 4.94 | 12.53% |
| INVU | 0.02 | 100.00% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
| CBDS | 0.06 | -25.00% |
| VKIN | 0.23 | 0.00% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| KNBIF Daily Charts |
KNBIF Intraday Charts |
Whats New @ Bazaartrend |
KNBIF Free Analysis |
|
|
KNBIF Important Levels Intraday
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
KNBIF Forecast May 2025
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | 0.05 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.05 |
KNBIF Weekly Forecast
| 4th UP Forecast | 0.07 |
| 3rd UP Forecast | 0.06 |
| 2nd UP Forecast | 0.06 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | 0.04 |
| 4th DOWN Forecast | 0.03 |
KNBIF Forecast2025
| 4th UP Forecast | 0.2 |
| 3rd UP Forecast | 0.15 |
| 2nd UP Forecast | 0.12 |
| 1st UP Forecast | 0.09 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.1 |
Kane Biotech Inc ( OTCQB USA Symbol : KNBIF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KNBIF Business Profile
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; medical device coatings under the Aledex name; and shampoos for dogs, cats, and horses under the Alosera name. It also offers anti-itch shampoo under the silkstem name; scalp detoxifiers, shampoos, and shampoo bars under the DermaKB Biofilm brand name; and wound care products under the Coactiv+ name. The company was incorporated in 2001 and is based in Winnipeg, Canada. Address: 162-196 Innovation Drive, Winnipeg, MB, Canada, R3T 2N2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service